🚀 VC round data is live in beta, check it out!

Veradigm Valuation Multiples

Discover revenue and EBITDA valuation multiples for Veradigm and similar public comparables like Artrya, Beijing Sunwayworld, Heren Health, Medley Inc. and more.

Veradigm Overview

About Veradigm

Veradigm Inc is a healthcare technology company that drives value through its various combinations of platforms, data, expertise, connectivity, and scale. The company delivers a combination of point-of-care clinical and financial solutions. The Veradigm Network features a dynamic community of solutions and partners providing insights, technology, and data-driven solutions for the healthcare provider, payer, and Life Science markets.


Founded

2000

HQ

United States

Employees

2.6K

Financials (LTM)

Revenue: $586M
EBITDA: $81M

EV

$231M

Valuation Multiples

Multiples.vc

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Veradigm Financials

Veradigm reported last 12-month revenue of $586M and EBITDA of $81M.

In the same LTM period, Veradigm generated $330M in gross profit, $81M in EBITDA, and $30M in net income.

Revenue (LTM)


Veradigm P&L

In the most recent fiscal year, Veradigm reported revenue of $588M and EBITDA of $58M.

Veradigm expects next 12-month revenue of XXX and NTM EBITDA of XXX

See Veradigm forward-looking valuation multiples
LTMNTMLast FYFY 2026FY 2027FY 2028
Revenue$586MXXX$588MXXXXXXXXX
Gross Profit$330MXXX$308MXXXXXXXXX
Gross Margin56%XXX52%XXXXXXXXX
EBITDA$81MXXX$58MXXXXXXXXX
EBITDA Margin14%XXX10%XXXXXXXXX
EBIT Margin7%XXX(3%)XXXXXXXXX
Net Profit$30MXXX($86M)XXXXXXXXX
Net Margin5%XXX(15%)XXXXXXXXX

Financial data powered by Morningstar, Inc.

Veradigm Stock Performance

Veradigm has current market cap of $458M, and enterprise value of $231M.

Market Cap Evolution


Veradigm's stock price is $4.21.

See Veradigm trading valuation data
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$231M$458M0.0%XXXXXXXXX$-0.79

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Veradigm Valuation Multiples

Veradigm trades at 0.4x EV/Revenue multiple, and 2.9x EV/EBITDA.

See valuation multiples for Veradigm and 15K+ public comps

EV / Revenue (LTM)


Veradigm Financial Valuation Multiples

As of April 20, 2026, Veradigm has market cap of $458M and EV of $231M.

Equity research analysts estimate Veradigm's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Veradigm has a P/E ratio of 15.0x.

LTMNTMLast FYFY 2026FY 2027FY 2028
Market cap (current)$458MXXX$458MXXXXXXXXX
EV (current)$231MXXX$231MXXXXXXXXX
EV/Revenue0.4xXXX0.4xXXXXXXXXX
EV/EBITDA2.9xXXX4.0xXXXXXXXXX
EV/EBIT5.7xXXX(11.8x)XXXXXXXXX
EV/Gross Profit0.7xXXX0.7xXXXXXXXXX
P/E15.0xXXX(5.3x)XXXXXXXXX
EV/FCF(5.8x)XXX2.8xXXXXXXXXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Veradigm Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Veradigm Margins & Growth Rates

Veradigm's revenue in the last 12 month grew by 0%.

Veradigm's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.1M for the same period.

Veradigm's rule of 40 is 14% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Veradigm's rule of X is 14% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for Veradigm and other 15K+ public comps

Veradigm Operational Valuation Multiples

LTMNTMLast FYFY 2026FY 2027FY 2028
Revenue Growth0%XXX(0%)XXXXXXXXX
EBITDA Margin14%XXX10%XXXXXXXXX
EBITDA Growth10%XXX34%XXXXXXXXX
Rule of 40—XXX14%XXXXXXXXX
Bessemer Rule of X—XXX14%XXXXXXXXX
Revenue per Employee—XXX$0.2MXXXXXXXXX
Opex per Employee—XXX$0.1MXXXXXXXXX
G&A Expenses to Revenue24%XXX—XXXXXXXXX
R&D Expenses to Revenue24%XXX17%XXXXXXXXX
Opex to Revenue—XXX56%XXXXXXXXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Veradigm Public Comps

See public comps and valuation multiples for other Healthcare Software and EHR & Practice Management comps.

EV/RevenueEV/EBITDA
LTM2026E2027ELTM2026E2027E
VeradigmXXXXXXXXXXXXXXXXXX
ArtryaXXXXXXXXXXXXXXXXXX
Beijing SunwayworldXXXXXXXXXXXXXXXXXX
Heren HealthXXXXXXXXXXXXXXXXXX
Medley Inc.XXXXXXXXXXXXXXXXXX
Weave CommunicationsXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXXXXXXX

Valuation data powered by FactSet, Inc.

Veradigm M&A Activity

Veradigm acquired XXX companies to date.

Last acquisition by Veradigm was on XXXXXXXX, XXXXX. Veradigm acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).

See M&A valuation multiples

Latest Acquisitions by Veradigm

Acquired CompanyValuationEV/RevenueEV/EBITDA
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.

Start Free Trial

Veradigm Investment Activity

Veradigm invested in XXX companies to date.

Veradigm made its latest investment on XXXXXXXX, XXXXX. Veradigm invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).

See VC round multiples

Latest Investments by Veradigm

CompanyValuationEV/RevenueEV/EBITDA
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Veradigm

When was Veradigm founded?Veradigm was founded in 2000.
Where is Veradigm headquartered?Veradigm is headquartered in United States.
How many employees does Veradigm have?As of today, Veradigm has over 2K employees.
Who is the CEO of Veradigm?Veradigm's CEO is Shih-Yin Ho.
Is Veradigm publicly listed?Yes, Veradigm is a public company listed on OTC Pink Sheets.
What is the stock symbol of Veradigm?Veradigm trades under MDRX ticker.
When did Veradigm go public?Veradigm went public in 1999.
Who are competitors of Veradigm?Veradigm main competitors are Artrya, Beijing Sunwayworld, Heren Health, Medley Inc..
What is the current market cap of Veradigm?Veradigm's current market cap is $458M.
What is the current revenue of Veradigm?Veradigm's last 12 months revenue is $586M.
What is the current revenue growth of Veradigm?Veradigm revenue growth (NTM/LTM) is 0%.
What is the current EV/Revenue multiple of Veradigm?Current revenue multiple of Veradigm is 0.4x.
Is Veradigm profitable?Yes, Veradigm is EBITDA-positive (as of the last 12 months).
What is the current EBITDA of Veradigm?Veradigm's last 12 months EBITDA is $81M.
What is Veradigm's EBITDA margin?Veradigm's last 12 months EBITDA margin is 14%.
What is the current EV/EBITDA multiple of Veradigm?Current EBITDA multiple of Veradigm is 2.9x.
What is the current FCF of Veradigm?Veradigm's last 12 months FCF is ($40M).
What is Veradigm's FCF margin?Veradigm's last 12 months FCF margin is (7%).
What is the current EV/FCF multiple of Veradigm?Current FCF multiple of Veradigm is (5.8x).

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial